BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33014187
Number of visits today
7539
Number of downloads
16204979
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Yan R, Dai W, Wu R, Huang H, Shu M. Therapeutic targeting m6A-guided miR-146a-5p signaling contributes to the melittin-induced selective suppression of bladder cancer. Cancer Letters 2022;534:215615. [DOI: 10.1016/j.canlet.2022.215615] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Mei Z, Mou Y, Zhang N, Liu X, He Z, Gu S. Emerging Mutual Regulatory Roles between m(6)A Modification and microRNAs. Int J Mol Sci 2023;24. [PMID: 36614216 DOI: 10.3390/ijms24010773] [Reference Citation Analysis]
2 Wen X, Wang J, Wang Q, Liu P, Zhao H. Interaction between N6-methyladenosine and autophagy in the regulation of bone and tissue degeneration. Front Bioeng Biotechnol 2022;10:978283. [DOI: 10.3389/fbioe.2022.978283] [Reference Citation Analysis]
3 Cai X, Liang C, Zhang M, Xu Y, Weng Y, Li X, Yu W. N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mao Y, Li W, Weng Y, Hua B, Gu X, Lu C, Xu B, Xu H, Wang Z. METTL3-Mediated m6A Modification of lncRNA MALAT1 Facilitates Prostate Cancer Growth by Activation of PI3K/AKT Signaling. Cell Transplant 2022;31:9636897221122997. [PMID: 36073002 DOI: 10.1177/09636897221122997] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345